What does TDL mean in LABORATORY

TDL is focused on developing innovative medicines targeted to specific diseases. We specialize in developing therapies that can help patients with conditions that are not adequately addressed by current treatments or don’t respond well to existing therapies.

While we have many therapeutic drug candidates in the research and development pipeline, no product has yet been approved for commercial use by a regulatory authority. However, we are continuing to progress our products through the clinical development stages and hope to have them available soon.

Our focus lies in investigating novel pathways and mechanisms underlying diverse disease states, such as cancer, autoimmune diseases and CNS disorders. We also have an exploration program which uncovers untapped potential in already existing drugs/compounds from biopharmaceutical companies.

We leverage precision medicine paradigms for target identification and validation based on biomarkers as well as data analytics approaches to identify promising lead compounds from complex datasets. To improve drug safety and efficacy further we employ cutting-edge technologies such as adaptive trials, AI-driven enrollment optimization, and using real-world evidence (RWE) when making decisions regarding clinical development strategies.

Yes! We have multiple partnerships with patient advocacy groups who help us ensure the voice of the patients is heard throughout all our efforts during drug discovery and development processes. Through these collaborations we are able to be in close communication with those whose needs our medicines seek to address.

No, Therapeutic Discovery Laboratories is a privately held company and is not publicly traded at this time.

Therapeutic Discovery Laboratories was incorporated in 2018 but has been actively working on researching and developing new treatments since then. Our team of experts bring over 40 years of combined experience in precision medicine, drug discovery, computational biology & AI, clinical operations & regulatory affairs.

Unlike other companies, we strive for excellence in everything we do; from finding new targets, designing innovative clinical trial designs based on advanced technology platforms such as machine learning or AI algorithms up to executing trials efficiently while keeping patient safety at top priority throughout all stages of drug development process.